Farrah S. Bakr

St John's Institute Of Dermatology, Guy's And St Thomas' NHS Foundation Trust
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Central Nervous System Tumors in Xeroderma Pigmentosum: Five Cases and Review of the Literature.

Central Nervous System Tumors in Xeroderma Pigmentosum: Five Cases and Review of the Literature.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: December 27, 2025

Primary Cutaneous Peripheral T-Cell Lymphoma NOS: Diagnostic Criteria and Challenges.

Primary Cutaneous Peripheral T-Cell Lymphoma NOS: Diagnostic Criteria and Challenges.

Journal: The American Journal of dermatopathology

Published: April 23, 2025

Real-life experience using topical chlormethine gel in the treatment of stage IA to IVA2 mycosis fungoides: a single-centre experience of 66 patients.

Real-life experience using topical chlormethine gel in the treatment of stage IA to IVA2 mycosis fungoides: a single-centre experience of 66 patients.

Journal: Clinical and experimental dermatology

Published: January 08, 2025

Ex vivo Sézary syndrome patient tumor cells are sensitive to ATR inhibition.

Ex vivo Sézary syndrome patient tumor cells are sensitive to ATR inhibition.

Journal: The Journal of investigative dermatology

Published: January 06, 2025

Homozygous Loss of CDKN2 in Primary Cutaneous CD8(+) Lymphoma NOS.

Homozygous Loss of CDKN2 in Primary Cutaneous CD8(+) Lymphoma NOS.

Journal: The American Journal of dermatopathology

Published: January 04, 2024

Mycosis Fungoides and Granulomatous Slack Skin: A Single Entity With Distinct Clinical Phenotypes.

Mycosis Fungoides and Granulomatous Slack Skin: A Single Entity With Distinct Clinical Phenotypes.

Journal: The American Journal of dermatopathology

Published: November 21, 2023

Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccine.

Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccine.

Journal: JAAD case reports

Published: November 07, 2022

Advances in the understanding and treatment of Cutaneous T-cell Lymphoma.

Advances in the understanding and treatment of Cutaneous T-cell Lymphoma.

Journal: Frontiers in oncology

Published: September 13, 2022

Follicular T-Helper Cells in Marginal Zone Lymphoma: Evidence of an Organoid Immune Response.

Follicular T-Helper Cells in Marginal Zone Lymphoma: Evidence of an Organoid Immune Response.

Journal: The American Journal of dermatopathology

Published: July 07, 2021

Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.

Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.

Journal: The American Journal of dermatopathology

Published: July 07, 2021

Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria.

Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria.

Journal: The American Journal of dermatopathology

Published: May 14, 2021

Frequent and Persistent PLCG1 Mutations in Sézary Cells Directly Enhance PLCγ1 Activity and Stimulate NFκB, AP-1, and NFAT Signaling.

Frequent and Persistent PLCG1 Mutations in Sézary Cells Directly Enhance PLCγ1 Activity and Stimulate NFκB, AP-1, and NFAT Signaling.

Journal: The Journal of investigative dermatology

Published: December 24, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026